Sfoglia per AUTORE
RICCI C
Collezione ASL Biella

  

Items : 8

Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study in Digestive and Liver Disease

2023
ASL Asti
ASL Biella
AOU Città della Salute di Torino

Terracciani F; De Vincentis A; D'Amato D; Invernizzi P; Morgando A; Vanni E; Viganò M; Alvaro D; Venere R; Lleo A; Colapietro F; Degasperi E; Viganò R; Giannini EG; Labanca S; Feletti V; Mussetto A; Cozzolongo R; Losito F; Pompili M; Ponziani FR; Niro GA; Cotugno R; Pozzoni P; Chessa L; Cuccorese G; Palitti VP; Russello M; Cannavò M; et alii...

Long-termreal-world experience with obeticholic acid in primary biliary cholangitis: the Italian recapitulate study in Journal of Hepatology

2023
ASL Biella
AOU Città della Salute di Torino

Terracciani F; Vincentis AD; D'Amato D; Morgando A; Vanni E; Viganò M; Alvaro D; Venere R; Lleo A; Colapietro F; Degasperi E; Viganò R; Giannini EG; Labanca S; Feletti V; Mussetto A; Cozzolongo R; Losito F; Pompili M; Ponziani F; Niro G; Cotugno R; Pozzoni P; Chessa L; Cuccorese G; Palitti VP; Russello M; Cannavò MR; Frazzetto E; et alii...

Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS) in Digestive and Liver Disease

2023
ASL Asti
ASL Biella
AOU Città della Salute di Torino

De Vincentis A; Terracciani F; D'Amato D; Invernizzi P; Morgando A; Vanni E; Viganò M; Alvaro D; Venere R; Lleo A; Colapietro F; Degasperi E; Viganò R; Giannini EG; Labanca S; Feletti V; Mussetto A; Cozzolongo R; Losito F; Pompili M; Ponziani FR; Niro GA; Cotugno R; Pozzoni P; Chessa L; Cuccorese G; Palitti VP; Russello M; Cannavò M; et alii...

Development and validation of a score predicting response to obeticholic acid in primary biliary cholangitis: the OCA response score (ORS) in Journal of Hepatology

2023
ASL Biella

Vincentis AD; Terracciani F; D'Amato D; Invernizzi P; Morgando A; Pellicano R; Vanni E; Viganò M; Alvaro D; Venere R; Lleo A; Colapietro F; Degasperi E; Viganò R; Giannini EG; Labanca S; Feletti V; Mussetto A; Cozzolongo R; Losito F; Pompili M; Ponziani F; Niro G; Cotugno R; Pozzoni P; Chessa L; Cuccorese G; Palitti VP; Russello M; et alii...

45TiP A randomized, molecular driven phase II trial of carboplatin-paclitaxel-bev vs carboplatin-paclitaxel-bev-rucaparib vs carboplatin-paclitaxel-rucaparib, selected according to HRD status, in patients with advanced ovarian cancer in Annals of Oncology

2022
ASL Biella

Carbone MV; Giudice E; Camarda F; Nero C; Tronconi F; Lorusso D; Ghizzoni V; Ricci C; Mosconi AM; Cormio G; Valabrega G; Zavallone L; Pignata S; Siena S; Scambia G; Salutari V; Musacchio L;

MITO 25.1: A RANDOMIZED, MOLECULAR DRIVEN PHASE II TRIAL OF CARBOPLATIN-PACLITAXELBEVACIZUMAB VS CARBOPLATIN-PACLITAXELBEVACIZUMAB- RUCAPARIB VS CARBOPLATINPACLITAXEL- RUCAPARIB, SELECTED ACCORDING TO HRD STATUS, IN PATIENTS WITH ADVANCED OVARIAN CANCER in International Journal of Gynecological Cancer

2022
ASL Città di Torino
ASL Biella

Musacchio L; Salutari V; Pignata S; Valabrega G; Zavallone L; Cormio G; Mosconi AM; Giolitto S; Camarda F; Ricci C; Zamagni C; Nero C; Carbone MV; Ghizzoni V; Sorio R; Salvatore S; Tronconi F; Savarese A; Scambia G; Lorusso D;

MITO 25.1: A RANDOMIZED, MOLECULAR DRIVEN PHASE II TRIAL OF CARBOPLATINPACLITAXEL- BEVACIZUMAB VS CARBOPLATIN-PACLITAXEL-BEVACIZUMABRUCAPARIB VS CARBOPLATIN-PACLITAXELRUCAPARIB, SELECTED ACCORDING TO HRD STATUS, IN PATIENTS WITH ADVANCED (STAGE III B-C-IV) OVARIAN, PRIMARY PERITONEAL AND FALLOPIAN TUBE CANCER in International Journal of Gynecological Cancer

2022
ASL Città di Torino
ASL Biella

Musacchio L; Salutari V; Pignata S; Valabrega G; Zavallone L; Cormio G; Mosconi AM; Giolitto S; Giudice E; Ricci C; Zamagni C; Nero C; Carbone MV; Ghizzoni V; Sorio R; Siena S; Tronconi F; Savarese A; Scambia G; Lorusso D;

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial in Journal of Translational Medicine

2020
ASL Cuneo 1
ASL Biella

Perrone F; Piccirillo MC; Ascierto PA; Salvarani C; Parrella R; Marata AM; Popoli P; Ferraris L; Marrocco-trischitta MM; Ripamonti D; Binda F; Bonfanti P; Squillace N; Castelli F; Muiesan ML; Lichtner M; Calzetti C; Salerno ND; Atripaldi L; Cascella M; Costantini M; Dolci G; Facciolongo NC; Fraganza F; Massari M; Montesarchio V; Mussini C; Negri EA; Botti G; et alii...